-
admin
Posts
Asian Machine Tool Online Exhibition 2026: Bridging Global Buyers and Asian Manufacturing Excellence
TAIPEI, April 21, 2026 /PRNewswire/ — The Asian Machine Tool Online Exhibition 2026 (AMTOE 2026) officially launches today, providing a comprehensive B2B sourcing platform that...
Automated and resource-efficient: tesa and AUMOVIO develop debondable adhesive solution for automotive displays
Rework and repair: debondable adhesive solutionbetween display assembly and housing – for rapid corrections in production and repairs throughout product life cycle Precise automation: adhesive...
Solidion Awarded Key Patents on Drop-In Solid-State Conversion Technology
Enables Solid-State Battery Production at Existing Li-Ion Facilities Without New Equipment DAYTON, Ohio, April 21, 2026 /PRNewswire/ — Solidion Technology Inc. (Nasdaq: STI), today announced...
HashKey Group Releases 3rd Web3 Economy Whitepaper: Reconstructing On-Chain Finance and Tokenization Infrastructure for the AI Agent Economy Era
HONG KONG, April 21, 2026 /PRNewswire/ — During the Web3 Festival, Dr. Xiao Feng, Chairman and CEO of HashKey Group, officially released the 3rd whitepaper...
Raytech Holding Limited Announces Strategic Expansion into Personal Health Care Electronics Services; Strengthens Leadership by Appointing Mr. Haoyuan Liu as Chairman and Executive Director
HONG KONG, April 20, 2026 (GLOBE NEWSWIRE) — Raytech Holding Limited (NASDAQ: RAY) (“RAY” or the “Company”) today announced a strategic expansion of its business...
Moonbird Claims Evaluated: Guided Breathing Therapy Device for Meditation-Like Calming Benefits for Relaxation & Sleep Support
A 2026 informational overview of Moonbird’s tactile breathing coach technology, EEG brain scan research references, real-time HRV biofeedback, pricing structure, and what prospective buyers should...
Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定,并通过 IND 审评
FDA 授予 Daretabart (hu1418K322A) 快速通道认定资格,以解决高危神经母细胞瘤领域存在的重大未满足医疗需求,允许该药物进入加速评审和滚动审评流程 FDA 通过新药临床研究 (IND) 申请后,即可在高危神经母细胞瘤复发及难治性患者中启动 SHINE II/III 期临床试验 Daretabart (hu1418K322A) 第一个商业化规模 GMP 生产批次已顺利完成 项目基于 II 期的积极数据,患者总生存率达 86.0% 英国 – 2026 年...
Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee
Company Marks First Annual Meeting at Historic Perkins Place Office Building as It Prepares to Relocate Its Headquarters from First Horizon Plaza Tower KNOXVILLE, Tenn.,...
Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy
First‑in‑class DARKFOX‑targeting bispecific T cell engager: ENA101 is designed to selectively recognize the DARKFOX‑A3 peptide presented by HLA‑A*03:01, a highly prevalent HLA allele, enabling precise...
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026
SHANGHAI, April 20, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to...
